戻る Agendas
PANEL DISCUSSION WITH PUBLIC-PRIVATE PARTNERSHIP STAKEHOLDERS
Session Chair(s)
Fatiha Sadallah
Principal Scientific Manager
Innovative Medicines Initiative (IMI), Belgium
PPPs – a Trojan Horse of neoliberal development or an innovation opportunity for all stakeholders? In this session we invite to a lively panel discussion with all stakeholders to appreciate the mutual benefits and drawbacks of PPPs.
Speaker(s)
Panel Discussion
Matthias Gottwald
Bayer Pharma AG, Germany
Head R&D Policy and Networking
Panel Discussion
Jan Geissler, MBA
Patvocates, Germany
Managing Director
Panel Discusion
Ruxandra Draghia- Akli
European Commission- Research DG, Belgium
Director of the Health Directorate
Panel Discusion
Magda Chlebus, MA
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Executive Director, Science Policy & Regulatory Affairs
Panel Discussion
Isabelle Moulon, MD
European Medicines Agency, Netherlands
Head of Patients and Healthcare Professionals Department